Humana Stock Price, News & Analysis

An independent analysis from Florida State University reveals that Humana Inc. (NYSE: HUM) significantly impacts Florida's economy, contributing approximately $48 billion in total economic activity in 2022. The study estimates that Humana supports over 288,000 jobs, generating $18 billion in wages and $472 million in taxes. Humana employs around 11,000 Floridians and serves over 2.6 million health plan members across various programs. The analysis underscores Humana's ongoing commitment to improving health outcomes and economic well-being in Florida.

Humana Inc. (NYSE: HUM) has been recommended by the Indiana Family and Social Services Administration to receive a contract for the Medicaid Managed Long Term Services and Supports (MLTSS) program in Indiana, beginning in 2024. This contract allows Humana to expand its services, already supporting nearly 350,000 members in the state through various health plans. The initiative emphasizes a person-centered approach, leveraging technology and data analytics to enhance health outcomes and address disparities. The contract's initial term is four years, with options for renewal, allowing Humana to continue serving dually eligible Medicaid and Medicare members.

Humana Inc. (NYSE: HUM) and Aledade have announced a 10-year partnership aimed at enhancing value-based primary care for Medicare Advantage members. This collaboration builds on a successful relationship since 2019, which resulted in a 5% reduction in hospitalizations and 12% decrease in readmissions. By 2022, over 100,000 patients benefited from this value-based approach. The partnership will gradually expand through existing and new agreements, focusing on comprehensive care and risk sharing. Aledade aims to empower independent practices with technology and support, having generated over $1.2 billion in healthcare savings to date.

AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana's recent $500 million, 5.7% senior unsecured notes due March 13, 2026 and $750 million, 5.5% senior unsecured notes due March 15, 2053. The outlook for these ratings is stable. The issuance aims to replace existing term loans, pre-fund upcoming maturities, and support general corporate purposes. Humana's financial leverage was approximately 42% as of Dec. 31, 2022, which is expected to moderate to about 40% long-term. Despite elevated leverage, earnings before interest and taxes coverage remains strong at over 10 times.

Humana Inc. (NYSE: HUM) announced a public offering of $1.25 billion in senior notes, comprised of $500 million due 2026 and $750 million due 2053. Pricing was set at 99.984% and 96.431% of the principal amount respectively. The offering is expected to close on March 13, 2023. Net proceeds, estimated at $1.211 billion, will repay a $500 million Delayed Draw Term Loan and cover general corporate purposes. The company is also vulnerable to various financial risks and regulatory changes, impacting profitability and operations, particularly due to its heavy government contract reliance.

Humana Inc. (NYSE: HUM) has announced that President and CEO Bruce D. Broussard will present to investors at the Cowen Health Care Conference on Tuesday, March 7, 2023, at 9:10 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page, with a recommendation to log in 15 minutes early for system testing.

Humana is dedicated to improving health and well-being for its medical and specialty members while lowering costs. The company offers various clinical capabilities, including in-home care, behavioral health, and wellness solutions, aiming to simplify health care navigation for patients.

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, an increase of 12.4% from the previous $0.7875. The dividend is payable on April 28, 2023 to stockholders of record as of March 31, 2023. This reflects Humana's commitment to providing value to its shareholders while supporting integrated healthcare solutions. The company focuses on improving healthcare quality through in-home care, behavioral health, pharmacy services, and data analytics. Additional information is available on Humana's investor relations page.

Humana Inc. (NYSE: HUM) announces the Humana Foundation's new strategy aimed at advancing health equity by removing barriers in healthcare for seniors, veterans, and school-aged children. The Foundation will invest over $15 million in community partners and evidence-based programs, focusing on emotional connections and healthier nutrition. Notably, the Health Equity Innovation Fund has been established with $7.5 million to tackle chronic diseases. Initial grants include support for the UNC Eshelman Institute for Innovation and regional nutrition programs, enhancing access to healthier food options.